There is no single "best" medication for MS — the right one depends on your disease type, how active it is, and how your body responds
Multiple sclerosis medications fall into two main categories: disease-modifying therapies (DMTs), which slow the disease and reduce relapses, and symptom-management drugs, which treat pain, fatigue, muscle stiffness, and other effects. Your neurologist will recommend a DMT based on whether you have relapsing-remitting MS (the most common form), progressive MS, or a newly diagnosed case. The choice also depends on how aggressive your disease appears, what side effects you can tolerate, and whether you have other health conditions that rule out certain drugs.
Starting a DMT early — ideally within weeks of diagnosis — gives you the best chance of slowing disease progression. Most people try one medication, and if it works well and you tolerate it, you stay on it. If you have breakthrough relapses (new symptoms despite treatment) or side effects become unbearable, your neurologist will switch you to a different drug. This is normal and expected; finding the right fit sometimes takes trial and adjustment.
Key Takeaways
- Disease-modifying therapies are the core MS treatment and work best when started early; the "best" one is the one that slows your disease without side effects you cannot live with.
- Relapsing-remitting MS (the most common type) has more medication options than progressive forms, and your neurologist will choose based on disease activity and your medical history.
- Most people stay on their first medication if it controls relapses and they tolerate it well; switching happens only if breakthrough symptoms or side effects force the issue.
- Symptom medications (for pain, fatigue, muscle stiffness) are separate from disease-modifying drugs and are added as needed alongside your main treatment.
- Your neurologist, not you, should decide which medication to start; the choice requires understanding your MRI results, relapse history, and blood work.
Disease-modifying therapies for relapsing-remitting MS
If you have relapsing-remitting MS, you have the most medication options. First-line drugs — the ones neurologists typically start with — include interferon beta (Avonex, Betaseron, Rebif), glatiramer acetate (Copaxone), and teriflunomide (Aubagio). These are older, well-understood medications with decades of safety data. They reduce relapse rates by roughly 30 percent and are given by injection or mouth.
Second-line medications are stronger and work faster but carry higher risks. Fingolimod (Gilenya), dimethyl fumarate (Tecfidera), natalizumab (Tysabri), and ocrelizumab (Ocrevus) suppress the immune system more aggressively and can reduce relapse rates by 50 to 70 percent. Your neurologist may start with one of these if your disease looks particularly active on MRI, if you have had multiple relapses in a short time, or if you are young and want the most aggressive approach. These drugs require more frequent blood tests and, in some cases, screening for infections before you start.
Newer medications like cladribine (Mavenclad) and siponimod (Mayzent) are also available. Cladribine is given as a short course of tablets over two years and then stopped; siponimod is a daily pill for progressive-relapsing MS. Your neurologist will discuss which class fits your situation, your job (some require frequent infusions), and your comfort with monitoring.
Disease-modifying therapies for progressive MS
Progressive MS — whether primary progressive or secondary progressive — has fewer medication options because the disease works differently. Ocrelizumab is the only drug approved specifically for primary progressive MS and has shown modest benefit in slowing progression. For secondary progressive MS (relapsing-remitting that has shifted into a steady decline), mitoxantrone (a chemotherapy drug) and siponimod are options, though mitoxantrone is rarely used now because of heart and cancer risks.
If you have progressive MS, your neurologist may recommend staying on the DMT you started with during your relapsing phase, or switching to ocrelizumab if you have not tried it. The evidence for DMTs in progressive disease is weaker than in relapsing-remitting MS, which means your neurologist may also discuss whether a DMT is right for you at all, depending on how fast your disease is progressing and whether you are still having relapses.
What happens if your first medication is not working
Breakthrough relapses — new symptoms or MRI lesions despite being on a DMT — signal that your current medication is not controlling your disease well enough. This typically prompts a switch to a stronger drug or a different class. Your neurologist will review your MRI, ask about any new symptoms, and check your blood work before deciding whether to switch and to what.
Side effects are another reason to change medications. Interferon beta can cause flu-like symptoms that some people never adjust to. Fingolimod requires heart monitoring and can slow your pulse dangerously. Natalizumab carries a small risk of a serious brain infection called PML. If side effects are severe enough that you are skipping doses or considering stopping treatment altogether, tell your neurologist immediately — staying on a medication you cannot tolerate is worse than switching to one you can.
Switching usually happens within the first year or two of diagnosis. After that, if you are stable on a medication, neurologists generally recommend staying on it rather than switching for the sake of switching. Long-term data on your current drug is often more valuable than chasing the newest option.
Medications for MS symptoms
Disease-modifying therapies slow the disease but do not erase existing damage or treat the symptoms that damage causes. Muscle stiffness and spasticity are often treated with baclofen (a muscle relaxant taken by mouth) or tizanidine. Severe spasticity may warrant botulinum toxin injections into the affected muscles. Fatigue — one of the most common and disabling MS symptoms — sometimes responds to amantadine or methylphenidate, though the evidence is modest.
Pain from MS can be neuropathic (burning, tingling, shooting sensations) or musculoskeletal (from weakness or poor posture). Neuropathic pain often responds to gabapentin or pregabalin. Bladder and bowel problems are managed with anticholinergic medications, intermittent catheterization, or dietary changes depending on the problem. Depression and anxiety, which occur in many people with MS, are treated with standard antidepressants like sertraline or escitalopram.
Your neurologist or MS specialist will add these medications as symptoms emerge. They work alongside your DMT, not instead of it.
How your neurologist chooses which medication to start
Your neurologist will consider several things before recommending a specific DMT. The type of MS you have (relapsing-remitting, primary progressive, or secondary progressive) narrows the list immediately. The activity of your disease on MRI — how many lesions you have and whether they are new or old — influences whether to start with a milder first-line drug or jump to something stronger. Your relapse history matters too: if you had two relapses in the past year, your neurologist may recommend a more aggressive medication than if you had one mild relapse two years ago.
Your age, other medical conditions, and what medications you are already taking all factor in. If you have heart problems, fingolimod may not be safe. If you are pregnant or planning to become pregnant, some DMTs are safer than others. If you have a history of cancer, natalizumab (which increases cancer risk slightly) might be avoided. Your job and lifestyle matter as well: if you travel frequently and cannot get to an infusion center, a daily pill is more practical than a monthly IV drug.
Finally, your neurologist will discuss your preferences. Some people want the most aggressive treatment available; others prefer to start mild and escalate only if needed. Both approaches are reasonable, and your neurologist should explain the trade-offs of each before you decide together.
What to expect when starting a new medication
Before you start a DMT, your neurologist will order blood tests to check your liver and kidney function and screen for infections like hepatitis B and tuberculosis. Some medications require additional screening: natalizumab requires a blood test for JC virus (which causes PML), and fingolimod requires an eye exam and heart monitoring. These tests take a week or two, so plan ahead.
Once you start, you will have follow-up appointments every three to six months for the first year. Your neurologist will ask about side effects, check your blood work, and review any new symptoms. MRI scans are usually done annually to see whether your disease is stable, improving, or worsening on the medication. If everything looks good after a year, appointments may space out to every six to twelve months.
Most side effects appear in the first few weeks. Interferon beta causes flu-like symptoms that often improve with time or by taking the injection at night. Fingolimod can cause headache, diarrhea, or a slow heart rate. Natalizumab infusions sometimes cause headache or fatigue the day after. If side effects are mild and you can tolerate them, your neurologist will usually ask you to give the medication a few more weeks before deciding to switch. If they are severe, you may switch sooner.
Frequently Asked Questions
Can I stop taking my MS medication if I feel fine?
No. MS medications work by preventing relapses and slowing disease progression, not by treating symptoms you can feel. You may feel fine because the medication is working. Stopping it usually leads to new relapses within weeks or months. If you want to stop for any reason — side effects, cost, pregnancy planning — talk to your neurologist first; they may adjust your dose, switch you to a safer medication, or discuss a planned pause rather than stopping abruptly.
How long does it take to know if a medication is working?
Most neurologists wait at least six months to a year before deciding a medication is not working. Some drugs take time to reach full effect, and you need enough time to see whether new relapses occur. If you have a major relapse in the first few months, your neurologist may switch sooner, but minor side effects or a single MRI lesion usually do not trigger a change immediately.
Are newer MS medications always better than older ones?
Not necessarily. Newer drugs like fingolimod and natalizumab are more potent and work faster, but they also carry higher risks and require more monitoring. Older drugs like interferon beta have decades of safety data and work well for many people. Your neurologist will choose based on your disease activity and medical history, not on how new the drug is.
What if I cannot afford my MS medication?
Most MS medications are expensive, but manufacturers offer copay assistance programs that can reduce your out-of-pocket cost to zero or a small amount. Your neurologist's office or the drug manufacturer's patient support line can help you find these programs. Some states also have programs for uninsured or underinsured people. Do not skip doses because of cost; talk to your neurologist or a social worker about options.
Can I switch medications while pregnant or breastfeeding?
Some MS medications are safer in pregnancy than others. Interferon beta and glatiramer acetate have long safety records in pregnancy. Others like fingolimod and teriflunomide carry risks and should be stopped before conception. If you are planning pregnancy, tell your neurologist at least three to six months in advance so you can switch to a safer medication if needed. Breastfeeding is possible on most DMTs, but your neurologist will advise you on which ones are safest.